Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/05/2023 | 71.1% | B. Riley Securities | $4 → $4.5 | Maintains | Buy |
12/30/2021 | 128.14% | B. Riley Securities | $5 → $6 | Maintains | Buy |
07/29/2021 | 80.61% | Morgan Stanley | $5 → $4.75 | Maintains | Equal-Weight |
03/15/2021 | 90.11% | Morgan Stanley | $4.75 → $5 | Maintains | Equal-Weight |
02/02/2021 | 80.61% | Morgan Stanley | $5 → $4.75 | Maintains | Equal-Weight |
11/16/2020 | 23.57% | B of A Securities | $2.75 → $3.25 | Maintains | Underperform |
10/09/2020 | 14.07% | Morgan Stanley | $2.75 → $3 | Maintains | Equal-Weight |
06/22/2020 | 52.09% | Wells Fargo | $3.5 → $4 | Maintains | Equal-Weight |
06/08/2020 | — | JMP Securities | Reinstates | → Market Perform | |
05/19/2020 | 4.56% | Morgan Stanley | $8 → $2.75 | Maintains | Equal-Weight |
05/11/2020 | 166.16% | B. Riley Securities | $10 → $7 | Maintains | Buy |
03/04/2020 | 280.23% | B. Riley Securities | $12 → $10 | Maintains | Buy |
01/17/2020 | 242.21% | Wells Fargo | → $9 | Downgrades | Overweight → Equal-Weight |
What is the target price for Diversified Healthcare (DHC)?
The latest price target for Diversified Healthcare (NASDAQ: DHC) was reported by B. Riley Securities on September 5, 2023. The analyst firm set a price target for $4.50 expecting DHC to rise to within 12 months (a possible 71.10% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Diversified Healthcare (DHC)?
The latest analyst rating for Diversified Healthcare (NASDAQ: DHC) was provided by B. Riley Securities, and Diversified Healthcare maintained their buy rating.
When is the next analyst rating going to be posted or updated for Diversified Healthcare (DHC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Diversified Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Diversified Healthcare was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.
Is the Analyst Rating Diversified Healthcare (DHC) correct?
While ratings are subjective and will change, the latest Diversified Healthcare (DHC) rating was a maintained with a price target of $4.00 to $4.50. The current price Diversified Healthcare (DHC) is trading at is $2.63, which is out of the analyst's predicted range.